Don't get left behind! The modernized is coming. Check it out now.
Say goodbye to!
The new site is coming soon - go to the modernized
Working… Menu

US Phase I Study of ECT-001-CB in Patients With Sickle-Cell Disease

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details. Identifier: NCT04594031
Recruitment Status : Withdrawn (Preference given to gene therapy approaches by the SCD research community and patients' associations)
First Posted : October 20, 2020
Last Update Posted : July 5, 2022
California Institute for Regenerative Medicine (CIRM)
Information provided by (Responsible Party):
ExCellThera inc.

No Study Results Posted on for this Study
Study was withdrawn before participants were enrolled.
Recruitment Status : Withdrawn
Estimated Primary Completion Date : September 1, 2023
Estimated Study Completion Date : February 2, 2024